Hemostemix Inc.
Hemostemix Inc. (HEM.V) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HEM.V · as of Jun 8, 2026
Key Statistics
Explore Hemostemix Inc. Data
hem.v stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
hem.v competitorsHEM.V
BLAB.CN
DOSE.CN
MDMA.CN
MRVL.V
NARA.CNStock Performance
Full HistoryAbout Hemostemix Inc.
Hemostemix Inc. a biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patie…
what is hemostemix inc. · hem.v stock overview · hemostemix inc. company profile · who is hemostemix inc. ceo · hem.v TSXV · hemostemix inc. headquarters · hemostemix inc. business segments
About Stock Overview & Key Data
Hemostemix Inc. (HEM.V) is a Healthcare company in the Biotechnology industry, listed on TSXV since Nov 28, 2014. As of the latest trading session, HEM.V stock price is $0.06, with a market capitalization of $10.9M. The stock has returned -54.17% over the past 12 months and -38.89% year-to-date.
In fiscal year 2025, Hemostemix Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Hemostemix Inc. (HEM.V) stock price is $0.06. The stock is traded on TSXV under the ticker symbol HEM.V. The 52-week range is $0.04 – $0.16.